Enoxacin cream

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. The antibacterial activity against anaerobic bacteria is poor. Enoxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

The main ingredient of this product is: Enoxacin. Its chemical name is: 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid sesquihydrate.

This product is a white or light yellow emulsion base ointment.

It is suitable for the treatment of various bacterial infections of skin and soft tissues, such as impetigo, folliculitis, furuncle, burn wound infection, and tinea pedis combined with bacterial infection.

Local adverse reactions are rare. Long-term and large-scale use may also produce the same adverse reactions as systemic medication after absorption from the skin, such as: allergic reactions such as rash and skin itching, gastrointestinal reactions such as abdominal discomfort, diarrhea, nausea, central nervous system reactions such as dizziness and headache, and other reactions such as increased serum aminotransferase, increased blood urea nitrogen, and decreased peripheral blood white blood cells.

Patients with a history of allergy to this product or other quinolone drugs are contraindicated. Pregnant women, lactating women, children and patients with glucose-6-phosphate dehydrogenase deficiency are contraindicated. Patients with epilepsy should use with caution.

Precautions for children: Generally not for infants and young children. Precautions for pregnancy and lactation: Pregnant women should not use it. It can be used with caution only when there is an indication for use and the benefits outweigh the disadvantages. Breastfeeding women should stop breastfeeding when using it. Precautions for the elderly: Elderly patients often have impaired renal function. Since this product is partially excreted through the kidneys after being absorbed from the skin, it needs to be used in a reduced dose.

Long-term and excessive use, after local absorption, may produce the same drug interactions as systemic medications, such as increasing the blood concentrations of drugs such as cyclosporine and probenecid, and interfering with the metabolism of caffeine.

10g:0.1g

24 months

Mayinglong Pharmaceutical Group Co., Ltd.

• Founded in:

  1994-05-09

• Address:

  No. 100, Zhoujiawan, Nanhu, Wuchang, Wuhan, Hubei

• Tax NO.:

  91420100177701670K

• Registered Funds:

  431.053891 yuan

• Website:

  Log in to view

• Email:

  Log in to view